Blockchain Registration Transaction Record

CNS Pharmaceuticals to be Featured in Virtual Investor CEO Connect

CNS Pharmaceuticals, a biopharmaceutical company, to be spotlighted in Virtual Investor CEO Connect with CEO John Climaco participating in live webcast. Berubicin, their lead drug candidate, is in development for brain and CNS cancers.

CNS Pharmaceuticals to be Featured in Virtual Investor CEO Connect

This news matters as it highlights the participation of CNS Pharmaceuticals in a live webcast, providing insight into their lead drug candidate, Berubicin, and their ongoing efforts to develop novel treatments for brain and CNS cancers.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x3081b961957a38bf214b6dd10ddcbf99d8e98a620a07658e328863c8b7e8673f
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintfiloDJt4-9e8fff351cfb77ca52c436544f46c87b